Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other Non-Current Assets (2017 - 2025)

Acro Biomedical (ACBM) has 8 years of Other Non-Current Assets data on record, last reported at $4600.0 in Q2 2025.

  • For Q2 2025, Other Non-Current Assets changed 0.0% year-over-year to $4600.0; the TTM value through Jun 2025 reached $4600.0, changed 0.0%, while the annual FY2024 figure was $4600.0, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $4600.0 in Q2 2025 per ACBM's latest filing, roughly flat from $4600.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4600.0 in Q4 2023 and bottomed at $4230.0 in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $4415.0, with a median of $4415.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: changed 0.0% in 2021, then increased 8.75% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $4230.0 in 2021, then changed by 0.0% to $4230.0 in 2022, then rose by 8.75% to $4600.0 in 2023, then changed by 0.0% to $4600.0 in 2024, then changed by 0.0% to $4600.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $4600.0 in Q2 2025, $4600.0 in Q1 2025, and $4600.0 in Q4 2024.